Wells Fargo & Company Longboard Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 90,154 shares of LBPH stock, worth $3.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,154
Previous 8,353
979.3%
Holding current value
$3.07 Million
Previous $180,000
1253.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LBPH
# of Institutions
101Shares Held
34.1MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$112 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$100 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$94.9 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$85.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$80.5 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $462M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...